Cargando…
Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides
BACKGROUND: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation to combat the rapid increase in MDR bacterial pathogens. However, many AMPs closely resemble components of the human innate immune system and the ramifications of prolonged bacterial exposure to AMPs...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161045/ https://www.ncbi.nlm.nih.gov/pubmed/27650186 http://dx.doi.org/10.1093/jac/dkw381 |